Ratings by Berenberg (Gaurav Goparaju)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/27/2023 | Twist Bioscience | TWST | New Coverage | Buy (N/A) |
20.96 (91.55) |
336.78% | Details | |
| 8/28/2023 | Certara Inc. | CERT | Maintain | (N/A) |
|
Details | ||
| 8/22/2023 | PhenomeX Inc | CELL | Downgrade | Hold (Buy) |
0.95 (1.00) |
5.26% | Details | |
| 8/3/2023 | Certara Inc. | CERT | Maintain | Buy (N/A) |
|
Details | ||
| 6/6/2023 | 23andMe Holding | ME | Maintain | Buy (N/A) |
|
Details | ||
| 4/27/2023 | Relay Therapeutics | RLAY | Maintain | Buy (N/A) |
|
Details | ||
| 4/13/2023 | Absci Corp. | ABSI | Maintain | Buy (N/A) |
|
Details | ||
| 4/11/2023 | Ginkgo Bioworks Holdings Inc | DNA | Maintain | Buy (N/A) |
|
Details | ||
| 3/9/2023 | Certara Inc. | CERT | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2023 | Relay Therapeutics | RLAY | Maintain | Buy (N/A) |
|
Details | ||
| 2/22/2023 | AbCellera Biologics | ABCL | Maintain | Buy (N/A) |
|
Details | ||
| 11/29/2022 | 23andMe | ME | New Coverage | Buy (N/A) |
2.87 (0.61) |
-78.75% | Details | |
| 11/29/2022 | Ginkgo Bioworks Holdings Inc | DNA | New Coverage | Buy (N/A) |
1.99 (8.09) |
306.53% | Details | |
| 9/8/2022 | Certara Inc. | CERT | New Coverage | Buy (N/A) |
15.66 (8.10) |
-48.28% | Details | |
| 2/1/2022 | Relay Therapeutics | RLAY | New Coverage | Buy (N/A) |
22.13 (18.83) |
-14.91% | Details | |
| 2/1/2022 | Absci Corp. | ABSI | New Coverage | Buy (N/A) |
6.73 (7.78) |
15.6% | Details |
